Sutro Biopharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
/ 
Frequently asked questions
To buy Sutro Biopharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sutro Biopharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sutro Biopharma Inc. is STRO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sutro Biopharma Inc. has its primary listing on NASDAQ. You can trade Sutro Biopharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sutro Biopharma Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Sutro Biopharma Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Sutro Biopharma Inc..